Dr Cellapy SR Premium
- Manufacturer
- GM Holdings Co., Ltd
- Effective date
- 2020-01-21
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- full-release
- Hydrated at
- 2026-05-31 23:03:15
Label at a glance#
ProductDr Cellapy SR Premium
Active ingredientASCORBIC ACID
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69278-100-02 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-6c0f-a426-e053-dadaa90af4c2 | Dr. Cellapy SR Premium |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69278-100-02 | Dr Cellapy SR Premium | 1 in 1 BOX | KIT | 1 | 6 | |
| 69278-101-01 | Dr Cellapy SR Premium | 5 mL in 1 VIAL | LIQUID | 5 mL | 0.005 in 5mL | 6 |
| 69278-101-02 | Dr Cellapy SR Premium | 5 in 1 BOX | LIQUID | 0.005 in 5mL | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69278-100 | DR CELLAPY SR PREMIUM (ASCORBIC ACID) KIT [GM HOLDINGS CO., LTD] | 6 | Legacy NDC, 3 package rows | 20200121_1082fb92-5986-4960-8d60-508e07ba9f78.zip |
| 69278-101 | DR CELLAPY SR PREMIUM (ASCORBIC ACID) KIT [GM HOLDINGS CO., LTD] | 6 | Unmatched | 20200121_1082fb92-5986-4960-8d60-508e07ba9f78.zip |
| 69278-102 | DR CELLAPY SR PREMIUM (ASCORBIC ACID) KIT [GM HOLDINGS CO., LTD] | 6 | Unmatched | 20200121_1082fb92-5986-4960-8d60-508e07ba9f78.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ASCORBIC ACID | ACTIVE INGREDIENT | PQ6CK8PD0R | 5 | |
| ASCORBIC ACID | ACTIVE MOIETY | PQ6CK8PD0R | 5 | |
| .GAMMA.-AMINOBUTYRIC ACID | INACTIVE INGREDIENT | 2ACZ6IPC6I | 5 | |
| 1,2-HEXANEDIOL | INACTIVE INGREDIENT | TR046Y3K1G | 5 | |
| ADENOSINE CYCLIC PHOSPHATE | INACTIVE INGREDIENT | E0399OZS9N | 5 | |
| ALANINE | INACTIVE INGREDIENT | OF5P57N2ZX | 5 | |
| AMINOBENZOIC ACID | INACTIVE INGREDIENT | TL2TJE8QTX | 5 | |
| ARGININE | INACTIVE INGREDIENT | 94ZLA3W45F | 5 | |
| asparagine | INACTIVE INGREDIENT | 5Z33R5TKO7 | 5 | |
| aspartic acid | INACTIVE INGREDIENT | 30KYC7MIAI | 5 | |
| BASIC FIBROBLAST GROWTH FACTOR (HUMAN) | INACTIVE INGREDIENT | S3529G9M9V | 5 | |
| biotin | INACTIVE INGREDIENT | 6SO6U10H04 | 5 | |
| calcium chloride | INACTIVE INGREDIENT | M4I0D6VV5M | 5 | |
| CALCIUM PANTOTHENATE | INACTIVE INGREDIENT | 568ET80C3D | 5 | |
| COCARBOXYLASE | INACTIVE INGREDIENT | Q57971654Y | 5 | |
| cyanocobalamin | INACTIVE INGREDIENT | P6YC3EG204 | 5 | |
| cystine | INACTIVE INGREDIENT | 48TCX9A1VT | 5 | |
| cytosine | INACTIVE INGREDIENT | 8J337D1HZY | 5 | |
| FIBROBLAST GROWTH FACTOR-1 | INACTIVE INGREDIENT | G53298VN9Y | 5 | |
| FLAVIN ADENINE DINUCLEOTIDE | INACTIVE INGREDIENT | ZC44YTI8KK | 5 | |
| folic acid | INACTIVE INGREDIENT | 935E97BOY8 | 5 | |
| glutamic acid | INACTIVE INGREDIENT | 3KX376GY7L | 5 | |
| glutamine | INACTIVE INGREDIENT | 0RH81L854J | 5 | |
| GLUTATHIONE | INACTIVE INGREDIENT | GAN16C9B8O | 5 | |
| GLYCINE | INACTIVE INGREDIENT | TE7660XO1C | 5 | |
| guanosine | INACTIVE INGREDIENT | 12133JR80S | 5 | |
| histidine | INACTIVE INGREDIENT | 4QD397987E | 5 | |
| hydroxyproline | INACTIVE INGREDIENT | RMB44WO89X | 5 | |
| inositol | INACTIVE INGREDIENT | 4L6452S749 | 5 | |
| isoleucine | INACTIVE INGREDIENT | 04Y7590D77 | 5 | |
| leucine | INACTIVE INGREDIENT | GMW67QNF9C | 5 | |
| lysine | INACTIVE INGREDIENT | K3Z4F929H6 | 5 | |
| magnesium sulfate | INACTIVE INGREDIENT | DE08037SAB | 5 | |
| MECASERMIN | INACTIVE INGREDIENT | 7GR9I2683O | 5 | |
| menadione | INACTIVE INGREDIENT | 723JX6CXY5 | 5 | |
| METHIONINE | INACTIVE INGREDIENT | AE28F7PNPL | 5 | |
| NADIDE | INACTIVE INGREDIENT | 0U46U6E8UK | 5 | |
| NEPIDERMIN | INACTIVE INGREDIENT | TZK30RF92W | 5 | |
| niacinamide | INACTIVE INGREDIENT | 25X51I8RD4 | 5 | |
| ornithine | INACTIVE INGREDIENT | E524N2IXA3 | 5 | |
| PHENYLALANINE | INACTIVE INGREDIENT | 47E5O17Y3R | 5 | |
| potassium chloride | INACTIVE INGREDIENT | 660YQ98I10 | 5 | |
| PREZATIDE COPPER | INACTIVE INGREDIENT | 6BJQ43T1I9 | 5 | |
| proline | INACTIVE INGREDIENT | 9DLQ4CIU6V | 5 | |
| pyridoxine | INACTIVE INGREDIENT | KV2JZ1BI6Z | 5 | |
| retinol | INACTIVE INGREDIENT | G2SH0XKK91 | 5 | |
| riboflavin | INACTIVE INGREDIENT | TLM2976OFR | 5 | |
| serine | INACTIVE INGREDIENT | 452VLY9402 | 5 | |
| sodium phosphate | INACTIVE INGREDIENT | SE337SVY37 | 5 | |
| taurine | INACTIVE INGREDIENT | 1EQV5MLY3D | 5 | |
| THIAMINE MONONITRATE | INACTIVE INGREDIENT | 8K0I04919X | 5 | |
| THREONINE | INACTIVE INGREDIENT | 2ZD004190S | 5 | |
| thymine | INACTIVE INGREDIENT | QR26YLT7LT | 5 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | 5 | |
| tryptophan | INACTIVE INGREDIENT | 8DUH1N11BX | 5 | |
| tyrosine | INACTIVE INGREDIENT | 42HK56048U | 5 | |
| valine | INACTIVE INGREDIENT | HG18B9YRS7 | 5 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 5 |
Products#
Every source-derived product name is available through these pages.
- Dr Cellapy SR Premium
- ascorbic acid
- Dr. Cellapy SR Premium Solution
- WATER
- 1,2-HEXANEDIOL
- NEPIDERMIN
- BASIC FIBROBLAST GROWTH FACTOR (HUMAN)
- MECASERMIN
- FIBROBLAST GROWTH FACTOR-1
- PREZATIDE COPPER
- NADIDE
- COCARBOXYLASE
- FLAVIN ADENINE DINUCLEOTIDE
- RETINOL
- PYRIDOXINE
- THIAMINE MONONITRATE
- BIOTIN
- TOCOPHEROL
- RIBOFLAVIN
- AMINOBENZOIC ACID
- INOSITOL
- NIACINAMIDE
- CYANOCOBALAMIN
- MENADIONE
- CALCIUM PANTOTHENATE
- FOLIC ACID
- .GAMMA.-AMINOBUTYRIC ACID
- ASPARTIC ACID
- GLUTAMIC ACID
- ALANINE
- ARGININE
- ASPARAGINE
- GLYCINE
- CYSTINE
- GLUTAMINE
- ISOLEUCINE
- HYDROXYPROLINE
- HISTIDINE
- METHIONINE
- LEUCINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69278-100 | 69278-100-02 |
| 69278-101 | 69278-101-01, 69278-101-02 |
| 69278-102 | 69278-102-01, 69278-102-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | SOAP / TOPICAL | 0.2 %w/w | ||
| ARGININE | ARGININE | 94ZLA3W45F | POWDER, FOR SOLUTION / INTRAVENOUS | 7.07 %w/v | ||
| niacinamide | NIACINAMIDE | 25X51I8RD4 | CREAM / TOPICAL | NA | ||
| ARGININE | ARGININE | 94ZLA3W45F | TABLET, EXTENDED RELEASE / ORAL | 20 mg | ||
| aspartic acid | ASPARTIC ACID | 30KYC7MIAI | INJECTION / INTRAVENOUS | 22 mg | ||
| cyanocobalamin | CYANOCOBALAMIN | P6YC3EG204 | SOLUTION / ORAL | 60 mg/1000ml | ||
| proline | PROLINE | 9DLQ4CIU6V | INJECTION / INTRAVENOUS | 0.8 %w/v | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION / INTRAOCULAR | 24 mg | ||
| ARGININE | ARGININE | 94ZLA3W45F | TABLET, FILM COATED / ORAL | 25 mg | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | INJECTION, EMULSION / INTRAVENOUS | 0.02 %w/v | ||
| GLYCINE | GLYCINE | TE7660XO1C | CAPSULE, DELAYED RELEASE / ORAL | 50 mg | ||
| PHENYLALANINE | PHENYLALANINE | 47E5O17Y3R | INJECTION / INTRAVENOUS | 7.26 mg | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3.76 mg | ||
| serine | SERINE | 452VLY9402 | INJECTION, SOLUTION / INTRAVENOUS | 0.18 %w/v | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 0.38 %w/v | ||
| proline | PROLINE | 9DLQ4CIU6V | INJECTION, SOLUTION / INTRAVENOUS | 0.34 %w/v | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | INJECTION, SOLUTION / INTRAVENOUS | 11 mg | ||
| histidine | HISTIDINE | 4QD397987E | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 63 mg | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | CAPSULE / ORAL | 2 mg | ||
| METHIONINE | METHIONINE | AE28F7PNPL | INJECTION / INTRATHECAL | 0.01 %w/v | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | TABLET / ORAL | 16 mg | ||
| lysine | LYSINE | K3Z4F929H6 | INJECTION / INTRAMUSCULAR | NA | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | CREAM / TOPICAL | NA | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 40 mg | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / INTRAMUSCULAR | 10.6 mg | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| leucine | LEUCINE | GMW67QNF9C | CAPSULE / ORAL | 1 mg | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SOAP / TOPICAL | NA | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, SOLUTION / INTRAVENOUS | 0.42 %w/v | ||
| niacinamide | NIACINAMIDE | 25X51I8RD4 | GEL / TOPICAL | 25 mg | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / INTRABURSAL | ADJ PH | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION / INTRAPERITONEAL | 0.03 %w/v | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 3600 mg | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET / ORAL | 2.9 mg | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | INJECTION, SOLUTION / INTRAMUSCULAR | 0.14 %w/v | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION / INFILTRATION | 0.3 mg | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | CAPSULE / ORAL | 36 mg | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | INJECTION, SUSPENSION / INTRAVITREAL | 0.05 %w/v | ||
| niacinamide | NIACINAMIDE | 25X51I8RD4 | INJECTION / INTRAMUSCULAR | 2.5 %w/v | ||
| histidine | HISTIDINE | 4QD397987E | INJECTION, SOLUTION / INTRAVENOUS | 0.09 %w/v | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | SUSPENSION / ORAL | 40 mg | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | POWDER / RESPIRATORY (INHALATION) | 0.18 mg | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / INTRADERMAL | 0.2 %w/v | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | INJECTION, SOLUTION / INTRATHECAL | 1 mg | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | INJECTION / INFILTRATION | 0.33 mg | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | CAPSULE / ORAL | NA | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / ORAL | 10.35 mg | ||
| tryptophan | TRYPTOPHAN | 8DUH1N11BX | INJECTION / INTRAVENOUS | 1.65 mg | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | INJECTION / SUBCUTANEOUS | 0.38 %w/v | ||
| sodium phosphate | SODIUM PHOSPHATE | SE337SVY37 | SOAP / TOPICAL | 0.21 %w/w | ||
| calcium chloride | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION / OPHTHALMIC | 1 mg | ||
| THREONINE | THREONINE | 2ZD004190S | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 160 mg | ||
| isoleucine | ISOLEUCINE | 04Y7590D77 | INJECTION, SOLUTION / INTRAVENOUS | 0.21 %w/v | ||
| ARGININE | ARGININE | 94ZLA3W45F | INJECTION / INTRAVENOUS | 790 mg | ||
| magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET, COATED / ORAL | NA | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | TABLET / ORAL | 231 mg | ||
| valine | VALINE | HG18B9YRS7 | INJECTION / INTRAVENOUS | 0.84 %w/v | ||
| valine | VALINE | HG18B9YRS7 | INJECTION, SOLUTION / INTRAVENOUS | 0.2 %w/v | ||
| potassium chloride | POTASSIUM CHLORIDE | 660YQ98I10 | SUSPENSION / OPHTHALMIC | 0.03 %w/w | ||
| GLYCINE | GLYCINE | TE7660XO1C | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 200 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 9ca0ae73-99fb-2ef0-e053-2995a90afc21 | 1082fb92-5986-4960-8d60-508e07ba9f78 | 2020-01-21 | Warnings | 9ca0ae73-99fb-2ef0-e053-2995a90afc21 1082fb92-5986-4960-8d60-508e07ba9f78 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
